IP Library Granted Patent US 8,206,346
Granted Patent B2
US 8,206,346 · App. 12/838,934 · Granted Jun 26, 2012

Targeted drug delivery device and method

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,206,346
App. No.
12/838,934
Granted
Jun 26, 2012
Kind
B2
Abstract

A targeted drug delivery device is provided. The device comprises an elongated member with proximal and distal ends, a plurality of infusion ports associated with the distal end of the elongated member, and a selector mechanism for selectively placing an introducer port into fluid communication with at least one infusion port. A method for treating tissue is also provided. The method comprises introducing a medical device into the tissue, selecting a region of the tissue to treat, positioning the medical device in proximity to the region, and introducing a medicament through the device to treat only that region.

Claims (41)

1. A method of treating a lesion located remotely in tissue, comprising:

introducing a medical device comprising a plurality of ports into the tissue adjacent the lesion;

selecting a region of the lesion to treat;

selecting a port in proximity to the region;

introducing a medicament through the selected port, whereby the application of the medicament is focused in the selected lesion region;

selecting another region of the lesion to treat;

selecting another port in proximity to the second region; and

introducing a medicament through the second port, whereby the application of the medicament is focused in the other selected lesion region.

2. The method of claim 1 , wherein the medicament is a chemotherapeutic agent.

3. The method of claim 1 , wherein the lesion is a tumor.

4. The method of claim 1 , wherein the tissue is brain tissue.

5. The method of claim 1 , wherein the medicament introduced in the lesion region and the medicament introduced in the other region are different from each other.

6. The method of claim 1 , wherein the medicament is delivered via forced convection.

7. The method of claim 1 , wherein the medicament is introduced within an interstitial space formed by removing a tumor.

8. A method of treating an interstitial space located remotely in tissue, comprising:

providing a delivery device, the delivery device comprising:

an elongated tubular member having a proximal end, a distal end, and a plurality of lumens extending from the proximal end to the distal end;

an introduction port in fluid communication with the plurality of lumens;

a selector mechanism configured for selectively placing the introduction port in fluid communication with a lumen selected from the plurality of lumens; and

an inflatable balloon disposed adjacent the distal end of the elongated tubular member, the balloon including a plurality of ports, wherein the plurality of lumens are in fluid communication with the plurality of ports;

introducing the delivery device into the tissue adjacent the interstitial space;

adjusting the selector mechanism to place the introduction port in fluid communication with a selected lumen;

delivering a medicament through the selected lumen; and

inflating the inflatable balloon, wherein a size of the plurality of ports increase as the balloon is inflated.

9. The method of claim 8 , further comprising selecting a region of the interstitial space to be treated.

10. The method of claim 9 , further comprising rotating the delivery device to align with the selected region.

11. The method of claim 8 , wherein the balloon is inflated to control the size of the ports.

12. The method of claim 8 , wherein the medicament is delivered via forced convection.

13. A method of treating an interstitial space located remotely in tissue, comprising:

providing a delivery device, the delivery device comprising:

an elongated tubular member having a proximal end, a distal end, and a plurality of lumens extending from the proximal end to the distal end;

an introduction port in fluid communication with the plurality of lumens; and

a selector mechanism configured for selectively placing the introduction port in fluid communication with a lumen selected from the plurality of lumens;

introducing the delivery device into the tissue adjacent the interstitial space;

adjusting the selector mechanism to place the introduction port in fluid communication with a first selected lumen;

introducing a medicament through the first selected lumen;

flushing the introduction port with a biologically inactive fluid;

adjusting the selector mechanism to place the introduction port in fluid communication with a second selected lumen, the second selected lumen different from the first selected lumen; and

introducing a medicament through the second selected lumen.

14. The method of claim 13 , wherein the medicament introduced in the first lumen and the medicament introduced in the second lumen are different from each other.

15. The method of claim 13 , wherein the medicament introduced in the first lumen and the medicament introduced in the second lumen are introduced to different regions of the interstitial space.

Assignments (7)
NUNC PRO TUNC ASSIGNMENT Recorded Jun 7, 2020
From: STRYKER EUROPEAN HOLDINGS I, LLC
To: STRYKER EUROPEAN HOLDINGS III, LLC
Reel/Frame 052861/0001 →
CHANGE OF NAME Recorded Jun 7, 2020
From: STRYKER EUROPEAN HOLDINGS III, LLC
To: STRYKER EUROPEAN OPERATIONS HOLDINGS LLC
Reel/Frame 052860/0716 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT LISTED SERIAL NOS. 09/905,670 AND 07/092,079 PREVIOUSLY RECORDED AT REEL: 037153 FRAME: 0241. ASSIGNOR(S) HEREBY CONFIRMS THE NUNC PRO TUNC ASSIGNMENT EFFECTIVE DATE 9/29/2014. Recorded Mar 8, 2016
From: STRYKER MEDTECH LIMITED
To: STRYKER EUROPEAN HOLDINGS I, LLC
Reel/Frame 038043/0011 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT SERIAL # 09/905,670 AND 07/092,079 PREVIOUSLY RECORDED AT REEL: 037153 FRAME: 0034. ASSIGNOR(S) HEREBY CONFIRMS THE NUNC PRO TUNC ASSIGNMENT. Recorded Mar 8, 2016
From: STRYKER NV OPERATIONS LIMITED
To: STRYKER MEDTECH LIMITED
Reel/Frame 038039/0001 →
NUNC PRO TUNC ASSIGNMENT Recorded Nov 23, 2015
From: STRYKER NV OPERATIONS LIMITED
To: STRYKER MEDTECH LIMITED
Reel/Frame 037153/0034 →
NUNC PRO TUNC ASSIGNMENT Recorded Nov 23, 2015
From: STRYKER MEDTECH LIMITED
To: STRYKER EUROPEAN HOLDINGS I, LLC
Reel/Frame 037153/0241 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 17, 2011
From: BOSTON SCIENTIFIC SCIMED, INC.
To: STRYKER CORPORATION; STRYKER NV OPERATIONS LIMITED
Reel/Frame 025977/0335 →